PROMETIC (1)

symetry121

(0)

56030 Reads | 19 Comments | 3 People call this a favourite

• Add blog to favourites

• T.PLI:more inside buying

  
  
  322 Reads | 0 Comments | September 15, 2015
  
  

  Director Andrew Trevor Bishop purchased 10,000 shares of the stock in a transaction on Tuesday, September 15th. The stock was acquired at an average cost of C$1.81 per share, for a total transaction of C$18,100.00 Read more at http://www.stockhouse.com/companies/bullboard/t.pli/prometic-life-sciences-inc#kSpmw54Bjsxg8OJE.99

  ---

• T.PLI:RBC:Outperform rating for ProMetic Life Sciences Inc.

  
  
  699 Reads | 0 Comments | August 14, 2015
  
  

  RBC: Outperform rating for ProMetic Life Sciences Inc. According to RBC Capital Markets:   http://www.ge.tt/4yqOMCM2/v/0?c   August 13, 2015   ProMetic Life Sciences Inc.   Rating: Outperform   Speculative Risk   Q2/15 results in-line, $20MM in revenue expected in H2 2015 vs. our $16MM   Impact: Slight positive   First...

  ---

• T.PLI:McWhirter top pick today:)

  
  
  350 Reads | 0 Comments | August 7, 2015
  
  

  McWhirter PLI is his #3 pick today on BNN Market Call! Very positive remarks.

  ---

• T.PLI:NR:ORPHAN DRUG DESIGNATION TO PROMETICS PLASMA-DERIVED PLASMINOGEN DRUG

  
  
  290 Reads | 0 Comments | August 5, 2015
  
  

  European Commission Grants Orphan Drug Designation to ProMetic's Plasma-Derived Plasminogen Drug LAVAL, QUEBEC--(Marketwired - Aug. 4, 2015) - ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF), ("ProMetic" or the "Corporation") announced today that an orphan drug designation status has been granted for its human plasma derived plasminogen drug by the European...

  ---

• T.PLI:NR:ORPHAN DRUG DESIGNATION TO PROMETICS PLASMA-DERIVED PLASMINOGEN DRUG

  
  
  339 Reads | 0 Comments | August 4, 2015
  
  

  EUROPEAN COMMISSION GRANTS ORPHAN DRUG DESIGNATION TO PROMETIC’S PLASMA-DERIVED PLASMINOGEN DRUG LAVAL, QUEBEC, CANADA, – August 4, 2015 – ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF), (“ProMetic” or the “Corporation”) announced today that an orphan drug designation status has been granted for its human plasma derived plasminogen drug by the...

  ---

• T.PLI:..BNN top pick!

  
  
  346 Reads | 0 Comments | August 3, 2015
  
  

  link: it starts at around 50 minutes and 50 second. http://www.bnn.ca/Video/player.aspx?vid=663435 Regards

  ---

• T.PLI:insider buys up 1 million shares...

  
  
  348 Reads | 0 Comments | June 30, 2015
  
  

    Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction Volume or Value Price Jun 29/15 Jun 29/15 Clulow, Kurt Stefan Victor Control or Direction Common Shares 10 - Acquisition in...

  ---

• T.PLI:insider buys up 1 million shares...

  
  
  192 Reads | 0 Comments | June 30, 2015
  
  

    Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction Volume or Value Price Jun 29/15 Jun 29/15 Clulow, Kurt Stefan Victor Control or Direction Common Shares 10 - Acquisition in...

  ---